TNFRSF9 and type 1 diabetes mellitus: Due to this dual effect, activation of effector T cells in acute autoimmunity may prohibit the use of agonistic CD137 antibodies in clinical autoinflammatory states, including T1D, because activated T cells have upregulated mCD137 in these settings.